Company Monitoring Page for Takeda

latest headlines for company on cafepharma

HilleVax’s IPO hauls in $200M for clinical test of VLP norovirus vaccine from Takeda
MedCity News
Mon, 05/2/22 - 11:46 am
Tags:
IPOs, vaccines, HilleVax, Takeda, norovirus
Takeda/Evozyne Partnership Headlines Hot Week for Gene Therapy Deals
BioSpace
Wed, 04/6/22 - 07:37 pm
Tags:
Takeda, Evozyne, gene therapy, Rare Diseases
Takeda's gene therapy hunger not yet quelled as Evozyne pact extended for $400M in biobucks
Fierce Biotech
Tue, 04/5/22 - 11:13 am
Tags:
Takeda, gene therapy, Evozyne, R&D
Return of Takeda’s Parathyroid Hormone Injection Delayed Indefinitely
BioSpace
Tue, 03/22/22 - 11:16 pm
Tags:
Takeda, parathyroid, hypoparathyroidism, Natpara, FDA
After price deal, Takeda's lung cancer drug Exkivity wins UK green light ahead of J&J rival
Fierce Pharma
Mon, 03/21/22 - 10:33 pm
Tags:
Takeda, JNJ, Exkivity, non-small cell lung cancer, UK
Takeda's gene therapy ambitions rise another $2B in 4-program Code Bio pact
Fierce Biotech
Tue, 02/22/22 - 10:46 am
Tags:
Takeda, biobucks, gene therapy, Code Biotherapeutics
With sotrovimab in the balance, Biogen vet reunites with George Scangos at Vir; First woman to chair PhRMA has more in store at Takeda
Endpoints
Fri, 02/11/22 - 10:11 am
Tags:
Biogen, Vir Biotechnology, GSK, Johanna Friedl-Naderer, Takeda, PhRMA
Takeda taps a doctor turned patient—and spread-the-word artist—for rare disease awareness campaign
Fierce Pharma
Sat, 02/5/22 - 12:02 pm
Tags:
Takeda, pharma marketing, patients, Rare Diseases
Takeda shunts jewel of Shire takeover to new spinoff Oak Hill
Fierce Biotech
Tue, 02/1/22 - 10:33 am
Tags:
Takeda, HilleVax, Oak Hill Bio, Shire, M&A
FDA denies Denali's Takeda-partnered Alzheimer's drug from entering clinic
Fierce Biotech
Thu, 01/13/22 - 10:19 pm
Tags:
Denali Therapeutics, Takeda, Alzheimer's disease, FDA, DNL919
With Sanofi's mighty Dupixent chasing behind, Takeda's Eohilia suffers FDA rejection after mysterious delay
Fierce Pharma
Wed, 12/22/21 - 11:11 am
Tags:
Takeda, Eohilia, Sanofi, Dupixent, FDA, eosinophilic esophagitis
FDA clears Takeda drug for post-transplant CMV infections
Pharmaforum
Wed, 11/24/21 - 10:06 am
Tags:
Takeda, FDA, post-transplant CMV, Livtencity, maribavir
Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on the shelf
Fierce Biotech
Wed, 11/10/21 - 10:22 am
Tags:
Poseida Therapeutics, CAR-T, BCMA, Takeda
Takeda launches value-based pricing program for lung cancer med Alunbrig, promises more deals to come
Fierce Pharma
Mon, 11/8/21 - 10:54 am
Tags:
Takeda, Alunbrig, value-based pricing, drug pricing, lung cancer
Takeda to buy GammaDelta to accelerate allogeneic cell therapies development
Pharmaceutical Business Review
Thu, 10/28/21 - 10:37 am
Tags:
Takeda, GammaDelta Therapeutics, M&A, allogeneic cells, solid tumors
Egle Therapeutics nabs $46M as it looks to push into the clinic with next-gen Tregs platform
Fierce Biotech
Fri, 10/22/21 - 12:10 pm
Tags:
Egle Therapeutics, tregs, Takeda, funding
Takeda, Wave Life Sciences revise their $230M R&D collaboration, dropping discovery work
Endpoints
Tue, 10/19/21 - 10:51 am
Tags:
Takeda, Wave Life Sciences, R&D
Calithera buys itself a plan B
EP Vantage
Tue, 10/19/21 - 10:43 am
Tags:
Calithera Biosciences, Takeda, telaglenastat, sapanisertib, mivovatinib, lung cancer, B cell lymphoma
Taking aim at the brain, Takeda strikes up cell therapy R&D alliance with Immusoft
MedCity News
Thu, 10/14/21 - 11:04 am
Tags:
Takeda, cell therapy, B cell therapies, Immusoft, R&D
Poseida, Takeda partner to develop eight in vivo gene therapy programs
Pharmaceutical Business Review
Wed, 10/13/21 - 10:51 am
Tags:
Takeda, Poseida Therapeutics, gene therapy, drug development

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.